Who makes Anti-HER2 CAR-T cells?

Anti-HER2 CAR-T cells is developed by UTC Therapeutics Inc..

What development phase is Anti-HER2 CAR-T cells in?

Anti-HER2 CAR-T cells is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Anti-HER2 CAR-T cells

UTC Therapeutics Inc. · Phase 1 active Biologic

At a glance

Generic name	Anti-HER2 CAR-T cells
Sponsor	UTC Therapeutics Inc.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Anti-HER2 CAR-T cells CI brief — competitive landscape report
Anti-HER2 CAR-T cells updates RSS · CI watch RSS
UTC Therapeutics Inc. portfolio CI